cells

Established from a human primary effusion lymphoma (PEL). The cells contain two viral genomes: Epstein-Barr virus (EBV) and Kaposi sarcoma associated herpesvirus (KSHV, provisionally designed HHV-8).

Cell Type:

Leukocyte (unspec.)

Tissue Origin:

Species:

human

Research Area:

Immunotherapy / Hematology

Cell Characteristics:

Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline

Filter:

The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.

Protocol	Kit	Program	Cells	Efficiency	Viable Cells	Substrate		Format	Platform
	V	T-001	1e6	47%		Plasmid (general)	5 µg	100 µl	I/II/2b

Citations

Intrabodies targeting the Kaposi's sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells

Categories:

Transfection

Authors:

Corte-Real S, Collins C, Aires da Silva F, Silmas P, Barbas Iii C, Chang Y, Moore P and Goncalves J

In:

Blood (2005) 106(12): 3797-3802

BC-1

Transfection Information

Citations